Corbus Pharmaceuticals Holdings (CRBP) Cash from Financing Activities (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) recorded Cash from Financing Activities of $2.85 million in Q3 2025, down 88.6% from $25.04 million a year earlier.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Cash from Financing Activities (2013 - 2025) Analysis & Trends
On a TTM basis, Corbus Pharmaceuticals Holdings' Cash from Financing Activities came in at $2.84 million as of Sep 30, 2025, down 98.3% year-over-year; for FY2024, it was $166.58 million.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of 34.1% (FY2019 to FY2024).
- Across earlier years, Cash from Financing Activities came in at -$2.82 million in FY2023, -$533,615 in FY2022, $60.82 million in FY2021 (-60.7%) and $154.87 million in FY2020 (+302.7%).
- Quarterly Cash from Financing Activities has ranged from -$1.91 million in Q4 2023 to $106.58 million in Q1 2024 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Corbus Pharmaceuticals Holdings | 51.77 Mn | -464.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2.85 Mn |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | 25.04 Mn |
| Jun 30, 2024 | 34.97 Mn |
| Mar 31, 2024 | 106.58 Mn |
| Dec 31, 2023 | -1.91 Mn |
| Sep 30, 2023 | -821,000.00 |
| Jun 30, 2023 | 18,010.00 |
| Mar 31, 2023 | -113,010.00 |
| Dec 31, 2022 | 234,322.00 |
| Sep 30, 2022 | -110,704.00 |
| Jun 30, 2022 | -330,108.00 |
| Mar 31, 2022 | -327,125.00 |
| Dec 31, 2021 | 767,938.00 |
| Sep 30, 2021 | -102,693.00 |
| Jun 30, 2021 | -255,585.00 |
| Mar 31, 2021 | 60.41 Mn |
| Dec 31, 2020 | 21.74 Mn |
| Sep 30, 2020 | 46.73 Mn |
| Jun 30, 2020 | 43.47 Mn |
API Access
Corbus Pharmaceuticals Holdings Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();